Direct-acting antiviral treatment for chronic hepatitis C in people who use drugs in a real-world setting

BACKGROUND: Direct-acting antivirals (DAAs) offer high cure rates in people who inject drugs (PWID) with hepatitis C virus (HCV) infection. There are concerns regarding lower response rates among PWID in real life. We evaluated the outcome of DAA therapy in PWID in a real-world setting and the facto...

Descripción completa

Detalles Bibliográficos
Autores principales: Koustenis, Kanellos Rafail, Anagnostou, Olga, Kranidioti, Hariklia, Vasileiadi, Sofia, Antonakaki, Pinelopi, Koutli, Evangelia, Pantsas, Paris, Deutsch, Melanie, Manolakopoulos, Spilios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049240/
https://www.ncbi.nlm.nih.gov/pubmed/32127741
http://dx.doi.org/10.20524/aog.2020.0449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049240/
https://www.ncbi.nlm.nih.gov/pubmed/32127741
http://dx.doi.org/10.20524/aog.2020.0449

Ejemplares similares